Société Générale


SocGen CMD 2026: Enhancing the fortress, rewarding shareholders

21/09/26 -"SocGen’s 2026 CMD “enhances” its turnaround: 3% revenue CAGR, absolute cost cut (€16.3bn cost target in 2029), C/I ratio below 55%, and 13-14% ROTE by 2029 (above-15% from 2030), ..."

Pages
76
Language
English
Published on
21/09/26
You may also be interested by these reports :
21/09/26
SocGen’s 2026 CMD “enhances” its turnaround: 3% revenue CAGR, absolute cost cut (€16.3bn cost target in 2029), C/I ratio below 55%, and 13-14% ROTE ...

16/09/26
Reading European equities earnings dynamic, i.e. revisions, remains a brain torturing exercise for anyone wondering where the 2026 earnings growth at ...

08/09/26
We have decreased our TP on the back of our negative 2027 EPS revision (see below), as well as on the back of our trimmed dividend and buyback ...

07/09/26
Equity markets were roughly unchanged over the week ending September 5. Tensions in the Gulf continued to rise leading to a sharp rise in crude ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO